Close Menu

On Patents

There is little evidence for all the concern over gene patents hurting basic biomedical research, writes Timothy Caulfield at Science Progress. Caulfield, who studies health law and policy at the University of Alberta, says the justification makes logical sense and has some anecdotal evidence, but there is a lack of hard data. Furthermore, he says this debate overshadows the effect that "commercialization pressure" has on academic research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.